Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Benjamin

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Transfusion|May 8, 2024
In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assayAnne North, Katherine Ling, Guillaume Ricaud, et al.
Transfusion|May 12, 2010
Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008)Anne F Eder, Ross M Herron, Annie Strupp, et al.
Transfusion Medicine (Oxford, England)|August 2, 2022
Beyond COVID-19 and lessons learned in the United StatesRichard Gammon, Louis M Katz, Donna Strauss, et al.
Transfusion|January 13, 2025
Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen-reduced red cells in complex cardiac surgery patientsPhilip J Norris, Mars Stone, Clara Di Germanio, et al.
Transfusion|April 6, 2006
Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trialAlvaro Pineda, Jeffrey McCullough, Richard J Benjamin, et al.
Transfusion|January 28, 2009
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studiesJunya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, et al.
Transfusion|February 2, 2010
The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral ratesJorge A Rios, Junyong Fang, Yongling Tu, et al.
Transfusion|November 21, 2013
The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)Aaron A R Tobian, Alice K Fuller, Kristin Uglik, et al.
British Journal of Haematology|June 1, 2019
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemiaYesim Aydinok, Antonio Piga, Raffaella Origa, et al.
Transfusion|June 22, 2007
Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)Anne F Eder, Jean M Kennedy, Beth A Dy, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Transfusion|May 8, 2024
In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assayAnne North, Katherine Ling, Guillaume Ricaud, et al.
Transfusion|May 12, 2010
Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008)Anne F Eder, Ross M Herron, Annie Strupp, et al.
Transfusion Medicine (Oxford, England)|August 2, 2022
Beyond COVID-19 and lessons learned in the United StatesRichard Gammon, Louis M Katz, Donna Strauss, et al.
Transfusion|January 13, 2025
Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen-reduced red cells in complex cardiac surgery patientsPhilip J Norris, Mars Stone, Clara Di Germanio, et al.
Transfusion|April 6, 2006
Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trialAlvaro Pineda, Jeffrey McCullough, Richard J Benjamin, et al.
Transfusion|January 28, 2009
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studiesJunya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, et al.
Transfusion|February 2, 2010
The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral ratesJorge A Rios, Junyong Fang, Yongling Tu, et al.
Transfusion|November 21, 2013
The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)Aaron A R Tobian, Alice K Fuller, Kristin Uglik, et al.
British Journal of Haematology|June 1, 2019
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemiaYesim Aydinok, Antonio Piga, Raffaella Origa, et al.
Transfusion|June 22, 2007
Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)Anne F Eder, Jean M Kennedy, Beth A Dy, et al.
Pageof 9